Rare diseases
Investigational molecules
Locations
Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis
ItalyStudy on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome
ItalyStudy on RVU120 and Venetoclax for Patients with Acute Myeloid Leukemia After Previous Treatment Failure
ItalyStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
ItalyStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
ItalyStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
ItalyStudy on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)
ItalyStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
ItalyStudy on the Safety and Effectiveness of GSK5733584 with Dostarlimab and Carboplatin for Patients with Advanced Gynecological Tumors
ItalyA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
ItalyA Study of Baricitinib to Delay Type 1 Diabetes in Children and Adults at Risk of Developing the Disease
ItalyAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
